MedTrace Logo

ANGIOTENSIN AGENTS AND REDUCTION OF THE PRESCRIPTION OF ANTIDEPRESSANT DRUGS: A RETROSPECTIVE COHORT STUDY USING REAL-WORLD DATA

NCT04899206 · Status: WITHDRAWN · Type: OBSERVATIONAL

Last updated 2025-06-05

No results posted yet for this study

Summary

A retrospective cohort study will be performed by analyzing data obtained from the Catalan Southern Metropolitan data warehouse system, which collects data from both hospitalized and primary care patients from the Bellvitge University Hospital's area of influence. The investigators will begin by gathering information only on patients treated with antihypertensive drugs, which then will be stratified in two groups: 1) Angiotensin Agents group; 2) Other Antihypertensive Agents (Non-Angiotensin Agents) group. Afterwards, a separated analysis will be performed to assess the effects of ARBs and ACEIs separately on the prescription of antidepressant drugs.

Conditions

Interventions

DRUG

With an Antidepressant Drug

Current users of an antidepressant drug.

DRUG

Without an Antidepressant Drug

Non-current users of an antidepressant drug.

Sponsors & Collaborators

  • Institut d'Investigació Biomèdica de Bellvitge

    collaborator OTHER

  • Institut Català de la Salut

    collaborator OTHER

  • Sebastian Videla

    lead OTHER

Principal Investigators

  • Sebastián Videla, MD, PhD · Head of the Clinical Research Support Unit

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-04-12
Primary Completion
2021-12-20
Completion
2025-12-20

Countries

  • Spain

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04899206 on ClinicalTrials.gov